- Home
- AVIR vs RILY Comparison
AVIR vs RILY Comparison
Compare AVIR & RILY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVIR | RILY |
|---|---|---|
| Founded | 2012 | 1973 |
| Country | United States | United States |
| Employees | N/A | 1380 |
| Industry | Medicinal Chemicals and Botanical Products | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 434.5M | 349.8M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | AVIR | RILY |
|---|---|---|
| Price | $4.27 | $8.44 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | 318.7K | ★ 1.1M |
| Earning Date | 05-11-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $351,367,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.99 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.78 | $2.79 |
| 52 Week High | $6.45 | $11.24 |
Technical Indicators
Market Signals| Indicator | AVIR | RILY |
|---|---|---|
| Relative Strength Index (RSI) | 37.87 | 42.84 |
| Support Level | $4.04 | $8.16 |
| Resistance Level | $4.34 | $9.43 |
| Average True Range (ATR) | 0.22 | 0.79 |
| MACD | 0.01 | -0.20 |
| Stochastic Oscillator | 31.94 | 0.71 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
About RILY B. Riley Financial Inc.
BRC Group Holdings Inc is a diversified holding company offering a platform of businesses, including financial services (with complementary banking and wealth management businesses), telecom, retail, and investments in equity, debt, and venture capital. It serves retail, corporate, capital providers, and individual customers across different business lines. The Group reports its activities in seven reportable business segments: Capital Markets, Wealth Management, Lingo, magicJack, Marconi Wireless, UOL, and Consumer Products. Maximum revenue is generated from the Consumer Products segment, which offers mobile computing accessories and home furnishing products. Geographically, the Group derives its revenue from North America.